PT801559E - Processo para a preparacao de formas de dosagem oral contendo um antibiotico de beta-lactama - Google Patents
Processo para a preparacao de formas de dosagem oral contendo um antibiotico de beta-lactamaInfo
- Publication number
- PT801559E PT801559E PT96904039T PT96904039T PT801559E PT 801559 E PT801559 E PT 801559E PT 96904039 T PT96904039 T PT 96904039T PT 96904039 T PT96904039 T PT 96904039T PT 801559 E PT801559 E PT 801559E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- beta
- antibiotic
- granulate
- oral dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95200313 | 1995-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT801559E true PT801559E (pt) | 2002-09-30 |
Family
ID=8220003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96904039T PT801559E (pt) | 1995-02-08 | 1996-02-08 | Processo para a preparacao de formas de dosagem oral contendo um antibiotico de beta-lactama |
Country Status (19)
Country | Link |
---|---|
US (1) | US5948422A (pt) |
EP (1) | EP0801559B1 (pt) |
CN (1) | CN1125636C (pt) |
AT (1) | ATE216576T1 (pt) |
AU (1) | AU4789696A (pt) |
BG (1) | BG63528B1 (pt) |
BR (1) | BR9607189A (pt) |
CZ (1) | CZ293718B6 (pt) |
DE (1) | DE69620866T2 (pt) |
DK (1) | DK0801559T3 (pt) |
EA (2) | EA000361B1 (pt) |
ES (1) | ES2175073T3 (pt) |
HU (1) | HU227938B1 (pt) |
MX (1) | MX9706062A (pt) |
NO (1) | NO319993B1 (pt) |
PL (1) | PL186386B1 (pt) |
PT (1) | PT801559E (pt) |
WO (1) | WO1996024337A1 (pt) |
ZA (1) | ZA961018B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI225402B (en) * | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
CN1225583A (zh) * | 1996-07-16 | 1999-08-11 | 吉斯特-布罗卡迪斯有限公司 | 无有机溶剂的β-内酰胺颗粒 |
US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
US6596311B1 (en) * | 1998-03-06 | 2003-07-22 | Eurand International S.P.A. | Fast disintegrating tablets |
US7399751B2 (en) * | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
DE19922537A1 (de) * | 1999-05-10 | 2000-11-16 | Roland Bodmeier | Darreichungsform zur Applikation in Körperöffnungen |
AU2001288102A1 (en) * | 2000-09-22 | 2002-04-02 | Takeda Chemical Industries Ltd. | Solid preparations |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
KR20030094244A (ko) * | 2001-02-05 | 2003-12-11 | 알.피.쉐러 테크놀러지즈 인코포레이티드 | 약리학적 활성제의 맛을 감소시키기 위한 방법 및 조성물 |
CN100337630C (zh) * | 2002-03-12 | 2007-09-19 | 布里斯托尔-迈尔斯斯奎布公司 | 可口的口服悬浮液及其制备方法 |
BRPI0314932B8 (pt) * | 2002-10-02 | 2021-05-25 | Meiji Seika Pharma Co Ltd | composição farmacêutica compreendendo cefditoren pivoxil amorfo e um ácido graxo de éster de sacarose |
DK1578422T3 (da) * | 2002-12-20 | 2007-07-02 | Niconovum Ab | Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale |
EP1648380B1 (en) * | 2003-07-03 | 2015-04-08 | Sertoli Technologies, LLC | Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
US20080255048A1 (en) * | 2005-11-17 | 2008-10-16 | Moise Azria | Pharmaceutical Composition |
US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
WO2008014470A2 (en) * | 2006-07-28 | 2008-01-31 | Sertocell Biotechnology (Us) Corp. | Adult sertoli cells and uses thereof |
WO2010031552A1 (en) * | 2008-09-17 | 2010-03-25 | Niconovum Ab | Process for preparing snuff composition |
CA2746768A1 (en) * | 2008-12-17 | 2010-07-08 | Altheus Therapeutics, Inc. | Enema formulations |
WO2023204773A1 (en) * | 2022-04-20 | 2023-10-26 | Bilim Ilac Sanayii Ve Ticaret A.S. | Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3344030A (en) * | 1964-06-15 | 1967-09-26 | American Home Prod | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables |
DE2251249A1 (de) * | 1972-10-19 | 1974-05-02 | Hoechst Ag | Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten |
DE2251250C3 (de) * | 1972-10-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten |
DE3887179T2 (de) * | 1987-03-02 | 1994-06-16 | Brocades Pharma Bv | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. |
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
ATE108996T1 (de) * | 1988-02-25 | 1994-08-15 | Brocades Pharma Bv | Verfahren zur herstellung eines pharmazeutischen granulats. |
US5643591A (en) * | 1991-01-16 | 1997-07-01 | Fmc Corporation | Solid dosage forms |
DE69525151T2 (de) * | 1994-04-13 | 2002-08-14 | Research Corp. Technologies, Inc. | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
-
1996
- 1996-02-08 ZA ZA9601018A patent/ZA961018B/xx unknown
- 1996-02-08 DK DK96904039T patent/DK0801559T3/da active
- 1996-02-08 HU HU9801677A patent/HU227938B1/hu not_active IP Right Cessation
- 1996-02-08 PT PT96904039T patent/PT801559E/pt unknown
- 1996-02-08 MX MX9706062A patent/MX9706062A/es unknown
- 1996-02-08 CN CN96191852A patent/CN1125636C/zh not_active Expired - Fee Related
- 1996-02-08 EA EA199700093A patent/EA000361B1/ru not_active IP Right Cessation
- 1996-02-08 BR BR9607189A patent/BR9607189A/pt active Search and Examination
- 1996-02-08 PL PL96321567A patent/PL186386B1/pl unknown
- 1996-02-08 EA EA199900205A patent/EA003736B1/ru not_active IP Right Cessation
- 1996-02-08 US US08/894,602 patent/US5948422A/en not_active Expired - Lifetime
- 1996-02-08 AU AU47896/96A patent/AU4789696A/en not_active Abandoned
- 1996-02-08 AT AT96904039T patent/ATE216576T1/de active
- 1996-02-08 DE DE69620866T patent/DE69620866T2/de not_active Expired - Lifetime
- 1996-02-08 ES ES96904039T patent/ES2175073T3/es not_active Expired - Lifetime
- 1996-02-08 EP EP96904039A patent/EP0801559B1/en not_active Expired - Lifetime
- 1996-02-08 CZ CZ19972302A patent/CZ293718B6/cs not_active IP Right Cessation
- 1996-02-08 WO PCT/EP1996/000547 patent/WO1996024337A1/en active IP Right Grant
-
1997
- 1997-08-07 NO NO19973646A patent/NO319993B1/no not_active IP Right Cessation
- 1997-08-08 BG BG101822A patent/BG63528B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
CN1125636C (zh) | 2003-10-29 |
BG63528B1 (bg) | 2002-04-30 |
EA199900205A1 (ru) | 2000-06-26 |
BR9607189A (pt) | 1997-11-11 |
HUP9801677A2 (hu) | 1998-11-30 |
EP0801559B1 (en) | 2002-04-24 |
NO319993B1 (no) | 2005-10-10 |
HUP9801677A3 (en) | 1999-05-28 |
EA199700093A1 (ru) | 1998-02-26 |
WO1996024337A1 (en) | 1996-08-15 |
CZ230297A3 (en) | 1997-11-12 |
AU4789696A (en) | 1996-08-27 |
ZA961018B (en) | 1997-08-08 |
BG101822A (en) | 1998-04-30 |
DE69620866D1 (de) | 2002-05-29 |
PL186386B1 (pl) | 2004-01-30 |
ES2175073T3 (es) | 2002-11-16 |
CZ293718B6 (cs) | 2004-07-14 |
NO973646L (no) | 1997-09-11 |
MX9706062A (es) | 1997-10-31 |
CN1173816A (zh) | 1998-02-18 |
EP0801559A1 (en) | 1997-10-22 |
US5948422A (en) | 1999-09-07 |
DE69620866T2 (de) | 2003-02-27 |
DK0801559T3 (da) | 2002-06-17 |
EA003736B1 (ru) | 2003-08-28 |
NO973646D0 (no) | 1997-08-07 |
ATE216576T1 (de) | 2002-05-15 |
HU227938B1 (en) | 2012-06-28 |
EA000361B1 (ru) | 1999-06-24 |
PL321567A1 (en) | 1997-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT801559E (pt) | Processo para a preparacao de formas de dosagem oral contendo um antibiotico de beta-lactama | |
ZA965237B (en) | A composition and a process for the preparation thereof | |
DE59510740D1 (de) | Pharmazeutische zubereitung enthaltend metformin und verfahren zu deren herstellung | |
BR9407910A (pt) | Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto | |
JO1969B1 (en) | Granulation process for the preparation of rapidly dissolving and dissolving compounds containing a high amount of the drug | |
BR9810592A (pt) | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto | |
NZ333380A (en) | 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof | |
IL115920A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING omega-SUBSTITUTED 2,2-DICHLOROALKANECARBOXYLIC ACIDS, SOME SUCH NEW COMPOUNDS AND PROCESS FOR THEIR PREPARATION | |
ES2170258T3 (es) | Composiciones farmaceuticas con resina de intercambio ionico. | |
HUP0000141A2 (hu) | Eljárás legfeljebb 90 tömeg% gyógyhatású anyagot tartalmazó pelletek előállítására | |
BR9709858A (pt) | Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto | |
BR9609964A (pt) | Formulação sólida estável de sal de enalaprila e processo para preparação da mesma | |
BR9909637A (pt) | Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos | |
HUP9601321A2 (en) | Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds. | |
BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
BR9713569A (pt) | Processo para a redução de corantes de enxofre e de cuba. | |
HUP9802518A3 (en) | Sulfonamide-substituted benzopirane derivatives, process for producing them, their use as pharmaceuticals and pharmaceutical compositions containing them | |
HUP0003566A2 (hu) | Eljárás dózisforma előállítására, az előállított termék és alkalmazása | |
ATE215941T1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
GR74756B (pt) | ||
TW334424B (en) | L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition | |
UY24851A1 (es) | Derivados de ácidos n-acil-alfa-aminados | |
HUP9902478A2 (hu) | Vírusellenes gyógyszerkészítmények és eljárás azok előállítására | |
ECSP961662A (es) | Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion | |
PL322847A1 (en) | Condensed b-carbolins |